CrossRef Diversity in metabolic dysfunction-associated steatotic liver disease: a framework for precision medicine Donghyun Ko, Jordan Low, Peter Low, Damien Chua, Yock Young Dan, Vincent Chen, Jonathan A
KEY OBSERVATIONS Chat starts with an AI assistant, but requesting a real person connected me immediately
Many pharmaceutical companies have decided that the benefits outweigh the risks
Risk Factors History of stomach issues or motion sickness Rapid dose increases Starting at higher doses Large, high-fat meals Eating too quickly Dehydration Existing metabolic disorders or obesity Female gender (noted in some studies) Metabolic disorders such as obesity exacerbate nausea
The findings also could be influenced by the small number of people in the study, he adds
GLP-1 receptor agonists work like the naturally produced hormone, GLP-1